| Title |
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow‐responder adult patients
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2012
|
| DOI | 10.1002/14651858.cd008516.pub2 |
| Pubmed ID | |
| Authors |
Lior H Katz, Hadar Goldvaser, Anat Gafter‐Gvili, Ran Tur‐Kaspa |
| Abstract |
The standard length of peginterferon plus ribavirin treatment for chronic hepatitis C virus (HCV) genotype 1 infected patients is 48 weeks. However, the number of patients demonstrating a sustained virological response is not high. In order to improve sustained virological response, extending the length of the treatment period has been suggested. |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 95 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 12 | 13% |
| Student > Bachelor | 10 | 11% |
| Student > Postgraduate | 8 | 8% |
| Student > Ph. D. Student | 8 | 8% |
| Researcher | 6 | 6% |
| Other | 15 | 16% |
| Unknown | 36 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 33% |
| Nursing and Health Professions | 7 | 7% |
| Psychology | 6 | 6% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 7 | 7% |
| Unknown | 38 | 40% |